NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00699517,A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies,https://clinicaltrials.gov/study/NCT00699517,,COMPLETED,"The primary objective of the study is to compare the progression-free survival (PFS) in the 2 treatment arms

The secondary objectives of the study are :

* To compare the overall survival in the 2 treatment arms
* To compare the objective response rate in the 2 treatment arms
* To assess the safety profile of AVE8062 (in combination with the background cisplatin therapy)
* To assess the pharmacokinetics of AVE8062 and its main metabolite, RPR258063, using a population approach, in all patients enrolled in selected centers.",NO,Sarcoma,DRUG: OMBRABULIN (AVE8062)|DRUG: Placebo,"Progression free survival, until event or study cut-off date (Tumor assessment every 6 weeks)","Overall survival, until event or study cut-off date|Response rate, tumor assessment every 6 weeks|Safety profile, assessment every 3 weeks",,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE3,355,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",EFC10145|EudraCT 2007-003592-39,2008-06,2013-04,2013-04,2008-06-18,,2015-12-21,"Investigational Site Number 840004, Santa Monica, California, 90403, United States|Investigational Site Number 840003, Orlando, Florida, 32806, United States|Investigational Site Number 840005, Maywood, Illinois, 60153, United States|Investigational Site Number 840002, Newark, New Jersey, 07103, United States|Investigational Site Number 840007, Philadelphia, Pennsylvania, United States|Investigational Site Number 840001, San Antonio, Texas, 78229, United States|Investigational Site Number 056001, Bruxelles, 1200, Belgium|Investigational Site Number 056004, Haine-Saint-Paul, 7100, Belgium|Investigational Site Number 056005, Li√®ge, 4000, Belgium|Investigational Site Number 076007, Belo Horizonte, 30130-100, Brazil|Investigational Site Number 076008, Goiania, 74070-040, Brazil|Investigational Site Number 076003, Ijui, 98700 000, Brazil|Investigational Site Number 076004, Jau, 17210-120, Brazil|Investigational Site Number 076006, Novo Hamburgo, 93511 970, Brazil|Investigational Site Number 076002, Porto Alegre, 90020-090, Brazil|Investigational Site Number 076005, Porto Alegre, 90035 003, Brazil|Investigational Site Number 076009, Rio De Janeiro, 20230-130, Brazil|Investigational Site Number 250008, Bordeaux, 33076, France|Investigational Site Number 250002, Dijon, 21079, France|Investigational Site Number 250004, Lille, 59010, France|Investigational Site Number 250001, Lyon Cedex 03, 69437, France|Investigational Site Number 250010, Marseille, 13385, France|Investigational Site Number 250006, Montpellier Cedex, 34094, France|Investigational Site Number 250007, Nice Cedex 02, 06189, France|Investigational Site Number 250005, Rennes, 35000, France|Investigational Site Number 250003, Saint Cloud, 92210, France|Investigational Site Number 250012, Saint Priest En Jarez, 42270, France|Investigational Site Number 250009, Saint-Herblain, 44800, France|Investigational Site Number 348001, Budapest, 1134, Hungary|Investigational Site Number 348002, Debrecen, 4032, Hungary|Investigational Site Number 356005, Bangalore, 560054, India|Investigational Site Number 356003, Hyderabad, 500033, India|Investigational Site Number 356004, New Delhi, 110076, India|Investigational Site Number 380001, Aviano, 33081, Italy|Investigational Site Number 380003, Milano, 20133, Italy|Investigational Site Number 380004, Milano, 20141, Italy|Investigational Site Number 380002, Rozzano, 20089, Italy|Investigational Site Number 891001, Belgrade, 11000, Serbia|Investigational Site Number 891002, Sremska Kamenica, 21204, Serbia|Investigational Site Number 724004, Barcelona, 08025, Spain|Investigational Site Number 724001, Madrid, 28040, Spain|Investigational Site Number 724003, Pamplona, 31008, Spain|Investigational Site Number 826001, Bebington, CH63 4JY, United Kingdom|Investigational Site Number 826003, Bristol, BS2 8ED, United Kingdom|Investigational Site Number 826002, Newcastle Upon Tyne, NE4 6BE, United Kingdom",
